William P. Donnelly net worth and biography

William Donnelly Biography and Net Worth

Director of Quanterix

Bill Donnelly serves as the Chair of Quanterix’s Board of Directors. Bill has more than 20 years of senior leadership in Life Science Tools and more than 25 years as a senior financial executive. For over 20 years he was a senior executive at Mettler-Toledo, including serving as EVP and Chief Financial Officer, as well as operating roles as a Division Head. Bill currently serves a lead independent director for Ingersoll Rand and as Chairman for John Carroll University’s Board of Directors where he graduated with a BSBA in Accounting.

What is William P. Donnelly's net worth?: The estimated net worth of William P. Donnelly is at least $1.07 million as of June 6th, 2025. Mr. Donnelly owns 139,094 shares of Quanterix stock worth more than $1,071,024 as of December 5th. This net worth evaluation does not reflect any other investments that Mr. Donnelly may own. Learn More about William P. Donnelly's net worth.
How do I contact William P. Donnelly?: The corporate mailing address for Mr. Donnelly and other Quanterix executives is 900 MIDDLESEX TURNPIKE, BILLERICA MA, 01821. Quanterix can also be reached via phone at (617) 301-9400 and via email at [email protected]. Learn More on William P. Donnelly's contact information.
Has William P. Donnelly been buying or selling shares of Quanterix?: William P. Donnelly has not been actively trading shares of Quanterix within the last three months. Most recently, on Friday, June 6th, William P. Donnelly bought 93,113 shares of Quanterix stock. The stock was acquired at an average cost of $5.44 per share, with a total value of $506,534.72. Following the completion of the transaction, the director now directly owns 139,094 shares of the company's stock, valued at $756,671.36. Learn More on William P. Donnelly's trading history.
Who are Quanterix's active insiders?: Quanterix's insider roster includes Amol Chaubal (CFO), Marijn Dekkers (Director), William Donnelly (Director), David Duffy (SVP), John Fry (General Counsel), E Hrusovsky (CEO), Dawn Mattoon (VP), and Mark Roskey (SVP). Learn More on Quanterix's active insiders.
Are insiders buying or selling shares of Quanterix?: During the last year, Quanterix insiders bought shares 5 times. They purchased a total of 463,113 shares worth more than $2,625,443.83. The most recent insider tranaction occured on June, 13th when Director David R Walt bought 123,990 shares worth more than $761,298.60. Insiders at Quanterix own 6.8% of the company. Learn More about insider trades at Quanterix.
Information on this page was last updated on 6/13/2025.

William P. Donnelly Insider Trading History at Quanterix

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction	Details
6/6/2025	Buy	93,113	$5.44	$506,534.72	139,094
9/8/2023	Buy	20,200	$24.85	$501,970.00	28,438

William P. Donnelly Buying and Selling Activity at Quanterix

Quanterix Company Overview

Quanterix Corporation, a life sciences company, engages in development and marketing of digital immunoassay platforms that advances precision health for life sciences research and diagnostics in North America, Europe, the Middle East, Africa, and the Asia Pacific regions. The company offers HD-X instrument, a protein detection platform; and SR-X instrument that enables researchers to apply Simoa detection in an expanded range of applications. It also provides SP-X instrument that is based on Simoa planar array technology for the measurement of multiplex chemiluminescent immunoassays. The company's products include assays include all components required to run enzyme-based immunoassay, such as beads, capture and detector reagents, and enzyme reagents and substrate; and replacement parts, reagents, and antibodies. In addition, it offers contract research services, including sample testing, homebrew assay development, custom assay development, lucent diagnostic, and LDT testing services. The company primarily operates in the areas of neurology, oncology, cardiology, infectious diseases, and inflammation. It sells its products for the life science research sector primarily to laboratories associated with academic and governmental research institutions, as well as pharmaceutical, biotechnology, and contract research companies through a direct field sale, support organizations, and distributors or sales agents. The company was formerly known as Digital Genomics, Inc. and changed its name to Quanterix Corporation in August 2007. Quanterix Corporation was incorporated in 2007 and is headquartered in Billerica, Massachusetts.

Today's Range

Now: $7.70

$7.19

$7.89

50 Day Range

MA: $5.89

$4.94

$7.70

2 Week Range

Now: $7.70

$4.05

$12.94

Volume

1,157,780 shs

Average Volume

808,333 shs

Market Capitalization

$359.67 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.01